First Aid Shot Therapy, the developer of a range of over-the-counter treatments, has completed a $24m series C round led by Johnson & Johnson.
First Aid Shot Therapy (F.A.S.T.), a US-based company developing medicines imbibed in liquid shot form, closed a $24m series C round on Wednesday led by healthcare product manufacturer Johnson & Johnson.
Johnson & Johnson, which invested through its Johnson & Johnson Innovation – JJDC subsidiary, was joined by investors including Lumira Capital, Sofinnova Ventures, Redmile Group and HealthQuest Capital.
F.A.S.T. is working on developing and commercialising a range of over-the-counter medicines to treat everyday health concerns that are taken in…
